Jay Cormier

Joseph "Jay" Cormier, JD, PhD is a regulatory attorney with the law firm of Hyman, Phelps & McNamara, P.C. He brings a highly technical perspective to his work helping clients with regulatory strategy, compliance, and regulatory policy. With a doctorate in Pharmacology and experience as a scientist and reviewer at FDA, he understands the technical and regulatory nuances of drugs, biologics, medical devices, and veterinary medicine. He advises companies on the FDA approval process and current Good Manufacturing Practice (cGMP) with a particular focus on orphan products and advanced biotechnology.

Before joining HPM, Dr. Cormier worked in private practice, and as a pharmacologist in the Animal Biotechnology Interdisciplinary Group in FDA's Center for Veterinary Medicine from 2005 to 2011. While at FDA, Dr. Cormier was actively involved in developing policies on the regulation of genetically engineered animals, and evaluated the manufacturing of new animal drugs. He was a recipient of several FDA awards, including the Scientific Achievement Award and the Commissioner's Special Citation, and was a nominee for the New Reviewer Award.

Dr. Cormier currently works with companies of all sizes on early stage products, including companies leveraging the tools of modern molecular biology to engineer animals and human cells to improve human health, animal health, and economic and food security. He has extensive knowledge of genetic engineering, drug and medical device manufacturing, and drug and medical device product approval and promotion.